Volume 32, Issue 212 (9-2022)                   J Mazandaran Univ Med Sci 2022, 32(212): 140-146 | Back to browse issues page

XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Farmani M, Shahini Shams Abadi M, Ahmadi A, Arjmand M, Soleimai A, Habibi Dastenaei Z. Comparing Serum Procalcitonin Levels Between Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease and Patients with Acute Exacerbation of Asthma. J Mazandaran Univ Med Sci 2022; 32 (212) :140-146
URL: http://jmums.mazums.ac.ir/article-1-17473-en.html
Abstract:   (780 Views)
Background and purpose: Serum procalcitonin (PCT) indicates a bacterial infection that can reduce the administration of antibiotics. The aim of this study was to compare serum procalcitonin levels in patients with acute exacerbation of chronic obstructive pulmonary disease (COPD) and asthma and its relationship with lung function and inflammatory factors.
Materials and methods: In this cross-sectional study, patients with acute exacerbation of asthma (n= 46) and COPD (n= 23) attending Shahrekord Kashani Hospital were included. After obtaining clinical and demographic information, the participants underwent spirometry and the levels of procalcitonin, ESR, white blood cell and PMN counts were determined. Data were analyzed in SPSS V19.
Results: There were significant differences between patients with exacerbation of COPD and asthma in age, sex, ICU hospitalization, and FEV1 percentage (P <0.05) but no significant differences were seen in mean ESR, WBC and PMN (P> 0.05). PCT results in asthma and COPD patients were 8.7% and 56.5%, respectively (P<0.05). Logistic regression analysis showed that gender and FEV1 had significant effects on PCT level (odds ratio 0.192 and 0.958, respectively (P<0.05).
Conclusion: Procalcitonin in patients with exacerbation of COPD was significantly higher than that in patients with exacerbation of asthma, which indicates the role of exacerbation of bacteria in COPD.
Full-Text [PDF 601 kb]   (350 Downloads)    
Type of Study: Brief Report | Subject: Internal medicine

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Journal of Mazandaran University of Medical Sciences

Designed & Developed by : Yektaweb